Search Results
Xanomeline oxalate 5mg 5mg | Purity Not Available
Adooq Bioscience
Xanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageXanomeline oxalate 25mg 25mg | Purity Not Available
Adooq Bioscience
Xanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageXanomeline oxalate 10mg 10mg | Purity Not Available
Adooq Bioscience
Xanomeline oxalate is a potent agonist of muscarinic acetylcholine receptors (EC50 values are 0.3, 92.5, 5, 52, and 42 nM for M1, M2, M3, M4, and M5, respectively).
More Information Supplier PageLY2606368 5mg 5mg | Purity Not Available
Adooq Bioscience
LY2606368 is an inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity.
More Information Supplier PageLY2606368 25mg 25mg | Purity Not Available
Adooq Bioscience
LY2606368 is an inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity.
More Information Supplier PageLY2606368 10mg 10mg | Purity Not Available
Adooq Bioscience
LY2606368 is an inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity.
More Information Supplier PageBI-78D3 50mg 50mg | Purity Not Available
Adooq Bioscience
BI-78D3 is a competitive JNK (c-Jun N-terminal kinases) inhibitor (IC50 = 280 nM) that displays > 100 fold selectivity over p38?? and no activity at mTOR and PI-3K. BI 78D3 inhibits JIP1(JNK interacting protein 1)-JNK binding (IC50 = 500 nM).
More Information Supplier PageBMS-863233 (XL-413) 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier PageBMS-863233 (XL-413) 10mg 10mg | Purity Not Available
Adooq Bioscience
BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More Information Supplier Page